Dr. Roy Eldor serves as Chief Medical Director of Oramed Pharmaceuticals. He joined Oramed in 2016, bringing with him over twenty years of clinical and scientific experience.
Dr. Eldor is an endocrinologist, internist and researcher and is currently Director of the Diabetes Unit at the Institute of Endocrinology, Metabolism & Hypertension, Tel-Aviv Sourasky Medical Center. He previously served as Principal Scientist at Merck Research Laboratories, Clinical Research – Diabetes & Endocrinology, Rahway, New Jersey. Prior to that, he served as a senior physician in internal medicine at the Diabetes Unit in Hadassah Hebrew University Hospital, Jerusalem, Israel and the Diabetes Division at the University of Texas Health Science Center in San Antonio, Texas (under the guidance of Dr. R.A. DeFronzo).
Dr. Eldor is a recognized expert, with over 35 peer reviewed papers and book chapters and has been an invited speaker to numerous international forums. He received his MD and PhD from the Hebrew University of Jerusalem.